BBLG
Bone Biologics Corporation
NASDAQ · Healthcare · Medical - Devices · US
$0.57
+1.86%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-73.7%
Return on equity
-65.2%
Return on assets
-78.0%
Return on invested capital
0.00x
Asset turnover
-$2.6M
Cash from operations
$1.46
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026